Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | July 31, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |